Discover open access scientific publications

Search, annotate, share and cite publications

Publications by A Dispenzieri

Suppression of Uninvolved Immunoglobulins Defined by Heavy/Light Chain Pair Suppression Is a Risk Factor for Progression of MGUS

Leukemia

English

Increased Expression of Extracellular Matrix Metalloproteinase Inducer (CD147) in Multiple Myeloma: Role in Regulation of Myeloma Cell Proliferation

English

Quantification of Clonal Circulating Plasma Cells in Newly Diagnosed Multiple Myeloma: Implications for Redefining High-Risk Myeloma

English

Melphalan and Prednisone Versus Melphalan, Prednisone and Thalidomide for Elderly and/or Transplant Ineligible Patients With Multiple Myeloma: A Meta-Analysis

English

Racial Disparities in the Prevalence of Monoclonal Gammopathies: A Population-Based Study of 12 482 Persons From the National Health and Nutritional Examination Survey

English

Primary Therapy With Single Agent Bortezomib as Induction, Maintenance and Re-Induction in Patients With High-Risk Myeloma: Results of the ECOG E2A02 Trial

English

Response to Salvage Therapies and Outcome in Patients With Multiple Myeloma Relapsing After Pomalidomide Therapy

English

Risk Stratification in Myeloma by Detection of Circulating Plasma Cells Prior to Autologous Stem Cell Transplantation in the Novel Agent Era

English

Improvement in Renal Function and Its Impact on Survival in Patients With Newly Diagnosed Multiple Myeloma

English

Changes in Uninvolved Immunoglobulins During Induction Therapy for Newly Diagnosed Multiple Myeloma

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by A Dispenzieri

Suppression of Uninvolved Immunoglobulins Defined by Heavy/Light Chain Pair Suppression Is a Risk Factor for Progression of MGUS

Increased Expression of Extracellular Matrix Metalloproteinase Inducer (CD147) in Multiple Myeloma: Role in Regulation of Myeloma Cell Proliferation

Quantification of Clonal Circulating Plasma Cells in Newly Diagnosed Multiple Myeloma: Implications for Redefining High-Risk Myeloma

Melphalan and Prednisone Versus Melphalan, Prednisone and Thalidomide for Elderly and/or Transplant Ineligible Patients With Multiple Myeloma: A Meta-Analysis

Racial Disparities in the Prevalence of Monoclonal Gammopathies: A Population-Based Study of 12 482 Persons From the National Health and Nutritional Examination Survey

Primary Therapy With Single Agent Bortezomib as Induction, Maintenance and Re-Induction in Patients With High-Risk Myeloma: Results of the ECOG E2A02 Trial

Response to Salvage Therapies and Outcome in Patients With Multiple Myeloma Relapsing After Pomalidomide Therapy

Risk Stratification in Myeloma by Detection of Circulating Plasma Cells Prior to Autologous Stem Cell Transplantation in the Novel Agent Era

Improvement in Renal Function and Its Impact on Survival in Patients With Newly Diagnosed Multiple Myeloma

Changes in Uninvolved Immunoglobulins During Induction Therapy for Newly Diagnosed Multiple Myeloma